Techno Medica Co., Ltd. (TYO:6678)
Japan
· Delayed Price · Currency is JPY 1,807.00
-12.00 (-0.66%)
May 30, 2025, 1:15 PM JST
Techno Medica Revenue
In the fiscal year ending March 31, 2025, Techno Medica had annual revenue of 9.91B JPY, down -3.68%. Techno Medica had revenue of 3.46B in the quarter ending March 31, 2025, a decrease of -10.40%.
Revenue
9.91B
Revenue Growth
-3.68%
P/S Ratio
1.27
Revenue / Employee
41.79M
Employees
237
Market Cap
12.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 9.91B | -378.00M | -3.68% |
| Mar 31, 2024 | 10.28B | 916.00M | 9.78% |
| Mar 31, 2023 | 9.37B | -332.00M | -3.42% |
| Mar 31, 2022 | 9.70B | 659.00M | 7.29% |
| Mar 31, 2021 | 9.04B | -770.00M | -7.85% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |